Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
0.0676 CHF | +14.58% | -2.03% | +64.88% |
May. 01 | SIX Swiss Exchange Approves Delay in Spexis' FY23 Annual Report Publication | MT |
Apr. 17 | Santhera Pharmaceuticals Terminates Cystic Fibrosis Drug License Deal with Spexis | MT |
Business Summary
Number of employees: 28
Managers
Managers | Title | Age | Since |
---|---|---|---|
Jeffrey Wager
CEO | Chief Executive Officer | 62 | 21-12-29 |
Martin Jakobovic
DFI | Director of Finance/CFO | - | - |
Stephan Wehselau
COO | Chief Operating Officer | 55 | 21-12-29 |
Chief Tech/Sci/R&D Officer | 68 | 21-12-29 | |
Muriel Fleming
HRO | Human Resources Officer | - | Nov. 30 |
Members of the board
Members of the board | Title | Age | Since |
---|---|---|---|
Dan Hartman
BRD | Director/Board Member | 62 | 21-12-29 |
Dennis Ausiello
BRD | Director/Board Member | 78 | 21-12-29 |
Kuno Sommer
BRD | Director/Board Member | 68 | 12-08-31 |
Jeffrey Wager
CEO | Chief Executive Officer | 62 | 21-12-29 |
Robert Clarke
BRD | Director/Board Member | 56 | 21-12-29 |
Bernard Bollag
BRD | Director/Board Member | 63 | 13-05-31 |
Share class
Vote | Quantity | Free-Float | Company-owned shares | Total Float | |
---|---|---|---|---|---|
Stock A | 1 | 67,664,495 | 33,987,938 ( 50.23 %) | 0 | 50.23 % |
Company contact information
Sector
Annual profits - Rate of surprise
1st Jan change | Capi. | |
---|---|---|
+64.88% | 4.37M | |
-2.10% | 90.02B | |
-0.66% | 39.15B | |
-15.83% | 31.71B | |
+62.42% | 26.47B | |
-21.68% | 14.34B | |
-8.73% | 12.89B | |
-10.32% | 11.18B | |
-45.77% | 10.97B | |
+3.45% | 8.94B |
- Stock Market
- Equities
- POLN Stock
- Company Spexis AG